Obtained CE-IVD marking for Anyplex™ II RV16 Detection
Obtained CE-IVD marking for Anyplex™ plus MTB/NTM/DR-TB Detection
Simultaneous detection of 16 viruses using real-time instrumentation
Obtained CE-IVD marking for Anyplex™ FluA/B Typing Real-time Detection
Obtained CE-IVD marking for Anyplex™ FluA/New H1N1 Real-time Detection
Detection of T. vaginalis and M. hominis
Award of European Patent for Dual Priming Oligonucleotide (DPO™) Technology
Seegene. relocates the U.S. subsidiary
Seegene announces a new concept of Real-time multiplex diagnostic technology
Seegene Inc awarded for ‘Korea Ethics Management Award’ for three consecutiv...
2011 KOSDAQ Market's 'Hidden Champion'
Non-exclusive technology transfer contracting with United States' Akonni Biosyst...
Seegene Strengthens Position in Multiplex PCR with Award of United States Patent...
Seegene: Multiplex assays key to companion diagnostics
Seegene Introduces Anyplex™ II RV16 Detection Assay Ahead of Seasonal Onset fo...
Seegene Awarded European Patent for Dual Priming Oligonucleotide (DPO™) Techno...
Seegene Introduces Anyplex™ II STI-7 Detection Assay
Prepare for flu, respiratory viruses - Assays, one day, will differentiate infec...
